Page 15 - Tim Dyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex Increases Issued Share Capital to Create Treasury Shares Addex TherapeuticsApril 26, 2021 GMT Geneva, Switzerland, April 26, 2021 - Addex Therapeutics  Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has increased its share capital from 39,748,635 to 49,272,952 through the issue of 9,524,317 new registered shares at a nominal value of CHF1 each to Addex Pharma S.A, its 100...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum Addex TherapeuticsApril 26, 2021 GMT Geneva, Switzerland, April 26, 2021 - Addex Therapeutics  Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Tim Dyer, Chief Executive Officer, will present at the 4ᵗʰ Annual Neuroscience Innovation Forum (April 26 - 30, 2021). In his presentation, Mr Dyer will provide a c...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex Reports Full Year 2020 Financial Results and Provides Corporate Update Addex TherapeuticsMarch 11, 2021 GMT Strong cash and cash equivalents position at Dec 31, 2020 of $20.2M (CHF18.7M) Balance sheet further strengthened by $11.5M fundraising on January 11, 2021 Three clinical studies in neurology programs expected to start during H1 2021 Clinical stage neurology programs aimed at large underserved market opportunities (Epilepsy, Parkinson’s disease LID and Blepharospasm) Geneva, Switzerlan...

About Addex Therapeutics: Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential...

Indiana Gov. Eric Holcomb, a Republican, used an executive order to institute a mask mandate that took effect July 27. The blowback was almost instantaneous.